Clinical application of quantitative 99mTc-HYNIC-PSMA SPECT/CT in prostate cancer

被引：0
|
作者：
Gao, Y. [1 ]
Shi, J. [1 ]
机构：
[1] Zhengzhou Univ, Dept Nucl Med, Peoples Hosp, Henan Prov Peoples Hospital
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
190
引用
收藏
页码：S503 / S504
页数：2
相关论文
共 50 条
  • [21] Evaluation of 99MTc-HYNIC-PSMA avidity in subtypes of renal cell carcinoma tumors based on histopathologic results
    Fakhar, Yasaman
    Aryana, Kamran
    Aghaee, Atena
    Ghorbani, Hamidreza
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [22] Improving diagnostic efficacy of primary prostate cancer with combined 99mTc-PSMA SPECT/CT and multiparametric-MRI and quantitative parameters
    Zhang, Yu
    Shi, Yuanying
    Ye, Liefu
    Li, Tao
    Wei, Yongbao
    Lin, Zhiyi
    Chen, Wenxin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] 99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer
    Mir, Kahkashan
    Fatima, Shazia
    Batool, Sadaf
    Bokhari, Ayesha
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S204 - S204
  • [24] SPECT-CT imaging with [99mTc]PSMA-T4 in patients with recurrent prostate cancer
    Sergieva, Sonya
    Mangaldgiev, Radoslav
    Dimcheva, Milena
    Nedev, Kamen
    Zahariev, Zahary
    Robev, Bozhil
    NUCLEAR MEDICINE REVIEW, 2021, 24 (02) : 70 - 81
  • [25] Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
    Wang, Qi
    Ketteler, Svea
    Bagheri, Shamim
    Ebrahimifard, Ali
    Luster, Markus
    Librizzi, Damiano
    Yousefi, Behrooz H.
    BMC CANCER, 2024, 24 (01)
  • [26] First experience with PSMA-SPECT/CT using a 99mTc-labeled PSMA inhibitor for patients with biochemical recurrence of prostate cancer
    Reinfelder, Julia
    Kuwert, Torsten
    Prante, Olaf
    Wullich, Bernd
    Hennig, Peter
    Beck, Michael
    Sanders, James
    Ritt, Philipp
    Schmidt, Daniela
    Goebell, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [27] First experience with PSMA-SPECT/CT using a 99mTC-labeled PSMA inhibitor for patients with biochemical recurrence of prostate cancer
    Reinfelder, J.
    Kuwert, T.
    Beck, M.
    Sanders, J.
    Ritt, P.
    Wullich, B.
    Goebell, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S337 - S338
  • [28] CLINICAL APPLICATION OF 99MTC-GLUCOSAMINE PULMONARY SPECT/CT
    Angelides, S.
    Barnett, R.
    Engelbert, H.
    Mackay, H.
    Camden, B.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 18 - 18
  • [29] Pharmacokinetic Properties of 99mTc-PSMA: A New Radiopharmaceutical for SPECT Imaging of Prostate Cancer
    V. K. Tishchenko
    O. P. Vlasova
    A. I. Ivannikov
    S. A. Dorovatovskiy
    A. A. Pankratov
    N. B. Morozova
    A. V. Fedorova
    A. A. Lebedeva
    K. A. Kuzenkova
    E. D. Stepchenkova
    A. M. Khailov
    P. V. Shegai
    S. A. Ivanov
    A. D. Kaprin
    Physics of Atomic Nuclei, 2023, 86 : 2513 - 2518
  • [30] Study on the best acquisition time of 99mTc-PSMA SPECT for the prostate cancer imaging
    Peng, Ye
    Wang, Tao
    Li, Xiao
    Zuo, Changjing
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345